Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244855
Status:
COMPLETED
Last Update Posted:
2017-05-22
First Post:
2005-10-25
Brief Title:
Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Contiguous Stage II Grade 1 Follicular Lymphoma |
| Contiguous Stage II Grade 2 Follicular Lymphoma |
| Contiguous Stage II Marginal Zone Lymphoma |
| Cutaneous B-cell Non-Hodgkin Lymphoma |
| Noncontiguous Stage II Grade 1 Follicular Lymphoma |
| Noncontiguous Stage II Grade 2 Follicular Lymphoma |
| Noncontiguous Stage II Marginal Zone Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Stage I Grade 1 Follicular Lymphoma |
| Stage I Grade 2 Follicular Lymphoma |
| Stage I Marginal Zone Lymphoma |
| Stage III Grade 1 Follicular Lymphoma |
| Stage III Grade 2 Follicular Lymphoma |
| Stage III Marginal Zone Lymphoma |
| Stage IV Grade 1 Follicular Lymphoma |
| Stage IV Grade 2 Follicular Lymphoma |
| Stage IV Marginal Zone Lymphoma |
| Waldenstrom Macroglobulinemia |
Keywords: